...
首页> 外文期刊>BMC Nephrology >Poor predictability of QuantiFERON-TB assay in recipients and donors for tuberculosis development after kidney transplantation in an intermediate-TB-burden country
【24h】

Poor predictability of QuantiFERON-TB assay in recipients and donors for tuberculosis development after kidney transplantation in an intermediate-TB-burden country

机译:在中等结核病负担国家中,接受肾脏移植后肺结核发展的受体和供体中QuantiFERON-TB检测的可预测性差

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background Tuberculosis (TB) is a common opportunistic infection after kidney transplantation (KT). The QuantiFERON-TB-Gold In-Tube test (QFT) is widely used for assessing latent TB; however, it is currently unclear whether the pre-KT QFT of the recipient and donor can predict post-KT TB. Methods We retrospectively reviewed patients who received KT between January 2009 and December 2015 at Seoul National University Hospital. The QFT was performed in 458 KT recipients and 239 paired living donors, and 138 KT recipients underwent both the QFT and tuberculin skin test (TST). After excluding 12 patients diagnosed as having clinically latent TB, we evaluated whether the QFT of the recipient and donor was predictive for new-onset active TB after KT. Results The QFT was positive in 101 (22.1%) recipients and associated with clinically latent TB before KT ( P Conclusion The QFT of recipients or living donors pre-KT cannot predict the short-term development of post-KT TB in an intermediate TB-burden country.
机译:背景结核(TB)是肾脏移植(KT)后常见的机会性感染。 QuantiFERON-TB-金管内测试(QFT)被广泛用于评估潜在结核病。然而,目前尚不清楚受体和供体的KT前QFT是否可以预测KT后TB。方法我们回顾性分析了2009年1月至2015年12月在首尔国立大学医院接受KT的患者。 QFT在458名KT接受者和239位配对的活体供体中进行,其中138名KT接受了QFT和结核菌素皮肤测试(TST)。在排除了12名被诊断为具有临床潜伏性结核病的患者之后,我们评估了接受者和捐赠者的QFT是否可预测KT后新发活动性结核病。结果101名接受者(22.1%)的QFT阳性,并与KT之前的临床潜伏性结核有关(P结论KT之前接受者或活体供者的QFT不能预测中等TB-患者中KT后TB的短期发展。负担国家。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号